|
27 Sep 2019 |
AbbVie Receives FDA Approval of MAVYRET® (glecaprevir/pibrentasvir) to Shorten Treatment Duration to Eight Weeks for Treatment-Naïve Patients with Chronic Hepatitis C and Compensated Cirrhosis Across All Genotypes
|
|
27 Sep 2019 |
Meissa Vaccines Closes $30 Million Financing to Advance RSV Vaccine into Clinical Trials
|
|
27 Sep 2019 |
Curevo Vaccine Announces Interim Results of Phase I Clinical Trial of CRV-101
|
|
25 Sep 2019 |
Immunicum AB (publ) Announces Complete Topline Data Analysis from Phase II MERECA Trial
|
|
25 Sep 2019 |
Bavarian Nordic Announces U.S. FDA Approval of JYNNEOS™ (Smallpox and Monkeypox Vaccine, Live, Non-replicating) for Prevention of Smallpox and Monkeypox Disease in Adults
|
|
22 Sep 2019 |
LineaRx and Takis/Evvivax Anti-Cancer Vaccine Candidates Demonstrate Tumor Reduction
|
|
19 Sep 2019 |
PDS Biotechnology Reports Clinical Data for Its Novel Immunotherapy PDS0101 in Follow up to Phase 1 Human Trial
|
|
18 Sep 2019 |
FDA Accepts Merck’s Biologics License Application (BLA) and Grants Priority Review for V920, the Company’s Investigational Vaccine for Ebola Zaire Virus
|
|
17 Sep 2019 |
Transgene Receives Approval from the French Health Authority (ANSM) to Initiate Two Clinical Trials of its Lead myvac™ Individualized Immunotherapy TG4050
|
|
12 Sep 2019 |
Moderna Announces Positive Interim Results from Phase 1 Cytomegalovirus (CMV) Vaccine (mRNA-1647) Study and Progress Toward Phase 2 and Pivotal Trials
|
|
10 Sep 2019 |
Axon Announces Positive Results From Phase II ADAMANT Trial for AADvac1 in Alzheimer's Disease
|
|
10 Sep 2019 |
VBI Vaccines Announces Phase 2a Clinical Evaluation of VBI-1901 Cancer Vaccine Candidate in Combination with GSK’s AS01B Adjuvant System in Recurrent Glioblastoma Patients
|
|
09 Sep 2019 |
Pfizer Announces Positive Preliminary Results from a Proof-of-Concept Phase 2 Study (B7471003) of its 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive Disease and Otitis Media in Healthy Infants
|
|
05 Sep 2019 |
Largest Real-World Study of Immunotherapy Shows Men with Advanced Prostate Cancer with Low PSA had a Median Survival of Nearly Four Years after Treatment with PROVENGE® (sipuleucel-T)
|
|
04 Sep 2019 |
SutroVax Receives CARB-X Award for Up to $15 Million to Develop a Universal Vaccine to Prevent Group A Streptococcus Infections
|
|
04 Sep 2019 |
Janssen Announces U.S. FDA Breakthrough Therapy Designation for Investigational Prophylactic Vaccine for the Prevention of Respiratory Syncytial Virus in Older Adults
|
|
27 Aug 2019 |
Imcyse reports successful first-in-human Phase 1b study in type 1 diabetes with IMCY-0098
|
|
22 Aug 2019 |
Themis Bioscience Announces Exclusive License and Research Collaboration Agreement with MSD to Develop Vaccine Candidates
|
|
21 Aug 2019 |
Aimmune Enrolls First Patient in Phase 2 Trial of AR201 for Egg Allergy
|
|
20 Aug 2019 |
Tonix Pharmaceuticals Expands Preclinical Pipeline with Triple Reuptake Inhibitor, TNX-1600, for the Treatment of PTSD
|
|
20 Aug 2019 |
Vaxxilon Awarded CARB-X Grant to Advance Novel Prophylactic Vaccine to Prevent Klebsiella pneumoniae Infections
|
|
19 Aug 2019 |
ActoBio Therapeutics™ Receives IND Green Light for New Antigen-Specific Immunotherapy Study Aimed at Improving Celiac Patients' Tolerance of Gluten
|
|
19 Aug 2019 |
Inovio Completes Enrollment of its VGX-3100 Open-label Phase 2 Trial for Treatment of HPV-Related High-Grade Anal Dysplasia
|
|
14 Aug 2019 |
Gritstone Oncology Announces First Patient Dosed with SLATE, its “Off-The-Shelf” Neoantigen Immunotherapy
|
|
14 Aug 2019 |
Brain Cancer Patients Display Decreasing Tumor Biomarkers After Treatment with Novel Immunotherapy in AIVITA Biomedical's Phase 2 Clinical Trial
|
